Costs of major intracranial, gastrointestinal and other bleeding events in patients with atrial fibrillation – a nationwide cohort study

BACKGROUND: Use of oral anticoagulation therapy in patients with atrial fibrillation (AF) involves a trade-off between a reduced risk of ischemic stroke and an increased risk of bleeding events. Different anticoagulation therapies have different safety profiles and data on the societal costs of both...

Descripción completa

Detalles Bibliográficos
Autores principales: Jakobsen, Marie, Kolodziejczyk, Christophe, Klausen Fredslund, Eskild, Poulsen, Peter Bo, Dybro, Lars, Paaske Johnsen, Søren
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5469002/
https://www.ncbi.nlm.nih.gov/pubmed/28606079
http://dx.doi.org/10.1186/s12913-017-2331-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5469002/
https://www.ncbi.nlm.nih.gov/pubmed/28606079
http://dx.doi.org/10.1186/s12913-017-2331-z

Ejemplares similares